Intelligence · Clinical Pipeline
Agios Netherlands Pipeline
All ClinicalTrials.gov programs at Agios Netherlands — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Agios Netherlands has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AG-120
Agios Netherlands B.V.
Chondrosarcoma
1 trial -
AG-348
Agios Netherlands B.V.
Thalassemia
1 trial -
Enasidenib
Agios Netherlands B.V.
Hematologic Neoplasms
1 trial -
Mitapivat
Agios Netherlands B.V.
Anemia
1 trial -
Tebapivat
Agios Netherlands B.V.
Myelodysplastic Syndromes
1 trial -
Tebapivat
Agios Netherlands B.V.
Sickle Cell Disease
1 trial -
ivosidenib and nivolumab
Agios Netherlands B.V.
Advanced Solid Tumor
1 trial
Frequently asked questions
How many pipeline programs does Agios Netherlands have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs